FTC clears Valeant Pharma's purchase of Medicis

Associated Press Modified: November 16, 2012 at 9:46 am •  Published: November 16, 2012
Advertisement
;

NEW YORK (AP) — Canadian drugmaker Valeant Pharmaceuticals International Inc. said Friday that the Federal Trade Commission cleared its proposed purchase of dermatology products maker Medicis Pharmaceutical Corp.

Valeant said the antitrust regulatory agency has terminated a mandatory review of the deal. Valeant, which is based in Montreal, agreed to buy Medicis in September for $44 per share, or about $2.6 billion. That represented a premium of 39 percent over the latest closing price of Medicis stock.

Medicis shareholders are scheduled to vote on the deal on Dec. 7. The companies hope to complete the sale in early 2013.

Shares of Valeant rose $1.37, or 2.6 percent, to $53.69 in morning trading. Medicis stock picked up 50 cents to $43.29.


Advertisement


Trending Now



AROUND THE WEB

  1. 1
    Former OU coach Sunny Golloway goes off at Auburn
  2. 2
    Chelsea Clinton Is Pregnant
  3. 3
    Tulsa World: Missouri’s Frank Haith positioned to become TU’s basketball coach
  4. 4
    Oklahoma football: Peyton Manning stops by Sooners film session
  5. 5
    VIDEO: A look at the Air Jordan XX9 in Thunder colors
+ show more